We’re transforming the way pain is treated with Personalized Analgesics®

Personalized Analgesics®
the first precision medicine approach to pain

We have created a radically new R&D platform to transform and de-risk pain drug development

Watch our intro video

Need for new analgesics

The Pain Epidemic

There is a pain epidemic and an immense need for safe new analgesics

Chronic pain has become a key area of interest following global recognition of the opioid crisis, highlighting the dire need for safe novel treatments

The pain market will reach $91 billion by 2027

The Problem

The R&D Problem

Current treatments have limited efficacy with serious side effects and abuse potential

There is a severe lack of innovation in pain R&D

Pain has a very high (98%) attrition rate in clinical drug development

Many established players left research

WHY?

We believe there are two key reasons for the lack of innovation in pain;

The approach to pain R&D has not changed in 20 years with a reliance on non-translatable preclinical models and no 'target-to-disease' link established for research projects

Clinical development has focused only on a limited number of pain diseases with regulatory pathway. Our Pain Landscape® indicates 100’s of neglected conditions are associated with chronic pain

Our approach

Our Unique Solution

We have developed the first precision medicine approach to pain to create more effective treatments and increase clinical success.

Our novel bioinformatic network biology approach to research connected to our proprietary pain landscape database of 100’s of diseases allows us to link research targets to disease and significantly de-risked R&D.

Find out more about our technology

Learn more

Personalized Analgesics®

Our Personalized Analgesics® research platform brings together a network of databases linking drug targets, genetic and biological pathways to pain related diseases.